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Sympathetic neuronal apoptosis after nerve growth factor
(NGF) deprivation requires the activation of two events: a pro-
tein synthesis-dependent, Bax-dependent release of mitochon-
drial cytochrome c and a protein synthesis-independent, Bax-
independent development of competence. Unlike in most cells,
cytosolic cytochrome c is not sufficient to induce cell death in
NGF-maintained sympathetic neurons but can do so in neurons
that have developed competence. We report that cytosolic
cytochrome c-induced apoptosis in competent sympathetic
neurons is completely dependent on caspase-9. In addition, the
neuroprotective agents KCl and chlorophenylthio-cAMP are
potent inhibitors of the development-of-competence pathway
in NGF-deprived sympathetic neurons. We also find that the
development of competence is reversible. Readdition of NGF
reverses competence, and neurons can regain their resistance
to cytosolic cytochrome c. Importantly, we examined the mech-
anism of development of competence and report that the in-
ability of cytochrome c to activate caspases in NGF-maintained
sympathetic neurons can be overcome with exogenous Smac
that inhibits the inhibitor of apoptosis (IAP) family of proteins.
Microinjection of cytochrome c and Smac, but neither alone,
induces rapid cell death in NGF-maintained neurons. These
data suggest that development of competence may be the
result of the loss of the function of one or more members of the
IAP family of caspase inhibitors that is needed before cyto-
chrome c can activate caspases and induce cell death in
neurons.
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Neuronal death by apoptosis occurs extensively during develop-
ment and is also observed in numerous pathological situations
(Oppenheim, 1991; Deshmukh, 1998; Mattson, 2000; Yuan and
Yankner, 2000). The mechanism of neuronal apoptosis has been
widely studied in sympathetic neurons that are dependent on
nerve growth factor (NGF) for survival and undergo apoptosis
within 24–48 hr after NGF removal in culture (Martin et al.,
1988; Edwards et al., 1991; Deckwerth and Johnson, 1993; Desh-
mukh and Johnson, 1997). This death is prevented by inhibitors
of macromolecular synthesis, such as cycloheximide (Martin et
al., 1988), by depolarizing concentrations of potassium (Scott and
Fisher, 1970; Franklin and Johnson, 1992) and by cAMP analogs
that raise intracellular cAMP levels (Rydel and Greene, 1988).
Sympathetic neuronal death is also dependent on Bax and
caspases. Bax-deficient (Deckwerth et al., 1996) or caspase-
inhibited (Deshmukh et al., 1996; Troy et al., 1996; McCarthy et
al., 1997; Deshmukh et al., 2000) sympathetic neurons do not
undergo apoptosis after NGF deprivation.
Recent studies have examined the mechanism by which
caspases are activated during apoptosis. The critical event for
caspase activation in most cells appears to be the Bcl-2-family-
protein-regulated translocation of cytochrome c from the mito-
chondria to cytosol (Hengartner, 2000). Once in the cytosol,
cytochrome c presumably binds to Apaf-1 and promotes its mul-
timerization. The subsequent recruitment of procaspase-9 to this
complex induces the activation of caspase-9 and rapid apoptosis
(Budihardjo et al., 1999). Consistent with this model, cytosolic
microinjection of cytochrome c is sufficient to induce a rapid,
caspase-dependent death in many cell lines (Li et al., 1997;
Brustugun et al., 1998; Juin et al., 1999; Chang et al., 2000).
In contrast, in sympathetic neurons, the mitochondrial release
of cytochrome c is necessary but not sufficient to induce cell
death. NGF-deprived sympathetic neurons exhibit a Bax-
dependent loss of cytochrome c from the mitochondria that is
necessary for cell death (Deshmukh and Johnson, 1998; Neame et
al., 1998; Martinou et al., 1999). However, NGF-maintained sym-
pathetic neurons are remarkably resistant to cytosolic microinjec-
tion of cytochrome c, indicating that the cytosolic translocation of
cytochrome c is not sufficient to induce cell death in these
neurons (Deshmukh and Johnson, 1998; Neame et al., 1998).
Importantly, NGF deprivation induces another event, called the
development of competence, which is needed along with cyto-
chrome c to induce cell death in sympathetic neurons. Sympa-
thetic neurons that are deprived of NGF for a period, but kept
alive by a block in the cytochrome c-release pathway either by
addition of cycloheximide or Bax deficiency, die rapidly when
exposed to cytosolic cytochrome c (Deshmukh and Johnson,
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1998). Thus, NGF deprivation activates two pathways in sympa-
thetic neurons: a macromolecular synthesis-dependent, Bax-
dependent pathway that leads to cytochrome c release from the
mitochondria and a macromolecular synthesis-independent, Bax-
independent pathway that leads to the development of compe-
tence (Deshmukh and Johnson, 1998). Activation of both path-
ways is needed for apoptosis in sympathetic neurons. In this
study, we have examined the molecular mechanism of the
development-of-competence pathway.
MATERIALS AND METHODS
Reagents. All reagents were purchased from Sigma (St. Louis, MO) unless
otherwise stated. Collagenase and trypsin were purchased from Worthing-
ton Biochemical Corp. (Freehold, NJ). The phosphatidylinositol 3-kinase
(PI-3-kinase) inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-
one (LY294002) was purchased from Biomol (Plymouth Meeting, PA).
The caspase inhibitor boc-aspartyl(OMe)-fluoromethylketone (BAF)
was purchased from Enzyme Systems Products (Livermore, CA).
Untimed-pregnant (ICR) mice were purchased from Harlan Sprague
Dawley (Indianapolis, IN).
Sympathetic neuronal cultures. Primary cultures of sympathetic neurons
from the superior cervical ganglion were prepared from postnatal day 1
(P1) mice essentially as described previously for rats (Johnson and
Argiro, 1983; Deshmukh et al., 1996). Briefly, the dissected ganglia were
treated with collagenase (1 mg/ml) and then trypsin (2.5 mg/ml) for 30
min each at 37°C. The ganglia were triturated, and the dissociated cells
were plated on collagen-coated dishes in NGF-containing medium
(AM50). This medium contained Eagle’s minimum essential medium
with Earle’s salts (Invitrogen, Gaithersburg, MD) with the addition of 50
ng/ml 2.5S NGF, 10% fetal calf serum, 2 mM glutamine, 100 g/ml
penicillin, and 100 g/ml streptomycin; 20 M fluorodeoxyuridine, 20 M
uridine, and 3.3 g/ml aphidicolin were also included to reduce the
number of non-neuronal cells. ICR outbred mice (Harlan Sprague Daw-
ley) were used for all experiments except those involving Bax-deficient
and caspase-9-deficient sympathetic neurons. The genetic background of
Bax-deficient and caspase-9-deficient mice was C57BL/6; wild-type lit-
termates were used as controls in these experiments.
Bax/ and caspase-9/ mice. Breeding and genotyping of Bax-
deficient mice have been described previously (Knudson et al., 1995;
Deckwerth et al., 1996). Bax-deficient sympathetic neurons were isolated
from P1 mice. Breeding and genotyping of caspase-9-deficient mice were
performed as described previously (Kuida et al., 1998). Caspase-9-
deficient sympathetic neurons were isolated from embryonic day 17 mice
because of lethality associated with caspase-9 deficiency at later ages;
these cultures were maintained in NGF-containing medium for 6–7 d
(instead of the normal 4–5 d) before subjecting them to the experimental
conditions.
Culture conditions. Sympathetic neuronal cultures were grown in NGF-
containing medium (AM50) for 4–5 d and then either maintained in
AM50 or treated as follows. For NGF deprivation, cultures were rinsed
twice with medium lacking NGF (AM0: AM50 medium without NGF),
followed by the addition of AM0 containing goat anti-NGF-neutralizing
antibody (Ruit et al., 1992). Other conditions required the addition of 1
g/ml cycloheximide, 0.1 g/ml actinomycin D, 400 M chlorophenylthio-
cAMP (CPTcAMP), or 35 mM KCl to the anti-NGF-containing me-
dium. For experiments in which NGF or other agents were readded to
cultures after NGF-deprived neurons had developed competence, cul-
tures were rinsed three times with the AM0 medium and then incubated
in the appropriate medium.
Microinjection of cytochrome c and quantitation of cell death. Our
method for microinjecting sympathetic neurons with cytochrome c and
assessing cell death after the microinjections has been described previ-
ously (Deshmukh and Johnson, 1998). Briefly, sympathetic neuronal
cultures (1500–3000 cells), grown in the appropriate medium on
collagen-coated, 35 mm dishes (Corning, Corning, NY), were switched
to Leibovitz’s L-15 medium (Invitrogen) containing 100 g/ml penicillin
and 100 g/ml streptomycin just before injections. To identify the in-
jected cells, the microinjection solution (in mM: 100 KCl and 10 KPi, pH
7.4) contained rhodamine dextran (4 mg/ml). Microinjection solution
containing rhodamine dextran (dye) alone or dye plus cytochrome c
(5–25 mg/ml) was injected into the cytoplasm of neurons by using
Femtotips needles (Eppendorf, Inc., Madison, WI). Immediately after
the injections, the number of viable cells injected was determined by
counting the number of rhodamine-positive cells that had intact, phase-
bright cell bodies. Cultures were then switched to the appropriate me-
dium, and, at various times after injections, the number of viable,
injected neurons remaining was determined by using the same counting
criterion.
Immunohistochemical assessment of caspase-3 activation. Neuronal cul-
tures were immunostained as described previously (Deshmukh and John-
son, 1998). Briefly, sympathetic neurons (1500–3000 cells) were grown
on collagen-coated, 35 mm dishes (Corning) in the appropriate medium.
Neurons were microinjected with cytochrome c along with a nonspecific
mouse monoclonal antibody (IgG) to allow identification of the injected
cells. (The rhodamine dextran dye could not be used to mark the injected
cells in these experiments because this dye becomes cell permeable
during the immunohistochemical procedure.) After the microinjections,
cultures were washed once with PBS and then fixed with freshly made 4%
paraformaldehyde in PBS for 30 min at 4°C. Cultures were then washed
three times with Tris-buffered saline (TBS; 100 mM Tris-HCl, pH 7.6,
and 0.9% NaCl), exposed to blocking solution (TBS containing 5% goat
serum and 0.3% Triton X-100) for 30 min at room temperature, and
incubated in anti-active caspase-3 antibody (CM1 antibody kindly pro-
vided by Dr. Anu Srinivasan, IDUN Pharmaceuticals, San Diego, CA)
solution overnight at 4°C. The primary antibody was diluted 1:5000 in
TBS containing 1% goat serum and 0.3% Triton X-100. Cultures were
then washed three times with TBS and incubated in an anti-rabbit Alexa
Fluor 488-conjugated (Molecular Probes, Inc., Eugene, OR) secondary
antibody solution in TBS containing 1% goat serum and 0.3% Triton
X-100 for 2–4 hr at 4°C. Cultures were also incubated with an anti-mouse
Cy3-conjugated (Jackson ImmunoResearch, West Grove, PA) secondary
antibody solution to label the microinjected cells. After the secondary
antibody incubation, cultures were washed twice in TBS and stained with
the nuclear dye bisbenzimide (Hoechst 33258 used at 1 g/ml; Molecular
Probes, Inc.) for 15 min at room temperature. After washing twice with
TBS and adding one drop of mounting medium (50% glycerol, 0.1%
paraphenylenediamine in PBS) on the cells, a glass coverslip was placed
on the cells, and the samples were examined by fluorescence microscopy.
Western blot analysis. Sympathetic neurons (5000–10,000 cells) were
washed twice with ice-cold TBS and then lysed with the addition of
SDS-PAGE sample buffer. Samples were then boiled for 5 min and
resolved by SDS-PAGE (12% Tris-glycine gels; Novex, San Diego, CA).
The proteins were then transferred to polyvinyl difluoride membranes
(Millipore, Burlington, MA) and washed with TBS containing 0.1%
Tween 20 (TBST). After incubation of the membrane with a blocking
solution (5% nonfat milk in TBST) for 1 hr at room temperature, the
membrane was then incubated in primary antibody (in blocking solution)
overnight at 4°C. Immunoblots were then washed three times with TBST
and incubated in the appropriate secondary antibody (in blocking solu-
tion) for 2 hr at room temperature. Proteins were visualized by using the
SuperSignal Chemiluminescent Detection system (Pierce, Rockford, IL)
according to the manufacturer’s instructions. The anti-phospho-Akt an-
tibody (S473; New England Biolabs, Inc., Beverly, MA) was used at
1:1000 dilution, and the anti-tubulin antibody (Sigma) was used at
1:50,000 dilution.
RESULTS
Staurosporine induces the development of
competence in sympathetic neurons
Apoptosis in NGF-deprived sympathetic neurons requires both
the release of cytochrome c and the development of competence
(Deshmukh and Johnson, 1998). To determine whether the
development-of-competence pathway is also activated in other
models of sympathetic neuronal apoptosis, we examined whether
sympathetic neurons treated with 100 nM staurosporine (STS)
developed competence. Like NGF deprivation, 100 nM STS treat-
ment induces apoptosis with cytochrome c release and caspase
activation in sympathetic neurons (Deshmukh and Johnson,
2000). Therefore, we asked whether cytosolic microinjection of
cytochrome c was able to induce cell death in 100 nM STS-treated
neurons. These experiments were done in Bax-deficient neurons
to prevent any cell death that would otherwise occur with 100 nM
STS treatment alone. Microinjection of cytochrome c induced
rapid cell death in 100 nM STS-treated but not NGF-maintained
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sympathetic neurons (Fig. 1). Microinjection with the rhodamine
dextran dye alone did not induce any cell death in 100 nM
STS-treated neurons, indicating that these neurons did not die
simply because of the microinjection or because of treatment with
100 nM STS alone (Fig. 1). The observation that 100 nM STS
treatment induced competence and permitted cytochrome c to
induce cell death in sympathetic neurons indicates that the de-
velopment of competence is not unique to the apoptotic pathway
induced with NGF deprivation.
Depolarizing concentration of KCl or CPTcAMP inhibits
the development-of-competence pathway
Although NGF deprivation activates both the cytochrome c re-
lease and the development-of-competence pathways, whereas the
pathway leading to cytochrome c release is dependent on macro-
molecular synthesis and Bax function, the development-of-
competence pathway requires neither macromolecular synthesis
nor Bax function (Deshmukh and Johnson, 1998). Therefore,
these two pathways must diverge after NGF deprivation at a
point that is upstream of the macromolecular synthesis- and
Bax-dependent steps during sympathetic neuronal apoptosis.
To determine the point at which these two pathways diverge
after NGF removal and to characterize the components of the
signaling pathway that leads to the development of competence,
we examined whether neuroprotective agents such as a depolar-
izing concentration of K (35 mM KCl) or a cAMP analog (400
M CPTcAMP) that prevents sympathetic neuronal apoptosis
(Rydel and Greene, 1988; Edwards et al., 1991; Deckwerth and
Johnson, 1993) block the development-of-competence pathway.
Microinjection of cytochrome c did not induce cell death in
NGF-deprived, 35 mM KCl-treated neurons or NGF-deprived,
400 M CPTcAMP-treated neurons (Fig. 2). Control cells that
were deprived of NGF in the presence of cycloheximide devel-
oped competence and died rapidly after microinjection of cyto-
chrome c. Thus, both KCl and CPTcAMP inhibited the
development-of-competence pathway in NGF-deprived sympa-
thetic neurons.
Inhibition of the PI-3-kinase signaling pathway leads to
the partial development of competence
We subsequently examined whether NGF signaling through the
PI-3-kinase pathway was essential for keeping the development-
of-competence pathway inhibited. Signaling through the PI-3-
kinase pathway has been reported to be important for maintain-
ing neuronal survival (see Discussion). Therefore, we examined
whether inhibiting the PI-3-kinase signaling pathway with
LY294002 (Vlahos et al., 1994) was sufficient to induce the
development of competence in NGF-maintained sympathetic
neurons.
Bax-deficient sympathetic neurons were treated with 50 M
LY294002 for 48 hr and then microinjected with cytochrome c
to assess whether these neurons had developed competence.
Bax-deficient neurons were used in these experiments to prevent
any cell death that would otherwise occur with LY294002 treat-
ment alone. Microinjection of cytochrome c but not dye alone
induced cell death in the PI-3-kinase-inhibited sympathetic neu-
rons (Fig. 3A). However, the kinetics and extent of cell death
induced by cytochrome c microinjection in LY294002-treated
neurons were reduced compared with the cell death induced by
cytochrome c microinjection in the control, NGF-deprived neu-
rons. Although microinjection of cytochrome c induced 60–70%
of neurons to die by 3 hr after the microinjections in NGF-
Figure 1. Activation of the apoptotic pathway with 100 nM STS induces
the development of competence in NGF-maintained sympathetic neu-
rons. Bax-deficient sympathetic neurons were maintained in NGF
(NGF ), deprived of NGF (NGF ), or maintained in NGF in the
presence of 100 nM STS (NGFSTS) for 36 hr. Bax deficiency permits
these neurons to be deprived of NGF or treated with 100 nM STS yet
remain alive, because the Bax is required for the release of cytochrome c
under these conditions. Neurons were then microinjected with cyto-
chrome c (10 mg/ml) and rhodamine dextran (C) or rhodamine dextran
alone (R), and the number of cells injected was determined after the
microinjections (time 0 hr) by counting using a fluorescent microscope. At
3, 6, and 12 hr after the injections, the number of microinjected cells that
remained viable was determined and expressed as a percentage of the
original number of microinjected cells. Microinjection of cytochrome c,
but not rhodamine dextran alone, induces rapid cell death in 100 nM
STS-treated neurons. Results are means  SEM for three experiments
with 100 cells counted for each time point per experiment.
Figure 2. KCl and cAMP block the development of competence in
NGF-deprived sympathetic neurons. Mouse sympathetic neurons were
deprived of NGF in the presence of 1 g/ml cycloheximide
(NGFCHX ), 35 mM KCl (NGFKCl ), or 400 M CPTcAMP
(NGFCPTcAMP) for 36 hr. Neurons were then microinjected with
cytochrome c (10 mg/ml), and the viability of the cells at 3, 6, and 12 hr
after the injections was determined as described in the legend to Figure 1.
Although the NGF-deprived, cycloheximide-saved cells developed com-
petence (microinjection of cytochrome c induced rapid cell death), both
KCl and CPTcAMP prevented the development of competence in these
neurons (microinjection of cytochrome c did not induce cell death). Data
shown are mean  range of two experiments with 100 cells counted for
each time point per experiment.
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deprived neurons that had developed competence, only 20% of
the LY294002-treated neurons died by 3 hr after microinjection
of cytochrome c (Fig. 3A). Even 12 hr after the cytochrome c
microinjections, although all of the NGF-deprived neurons had
died, 25% of the LY294002-treated, cytochrome c-microinjected
neurons still remained viable. The reduced cell death observed in
LY294002-treated, cytochrome c-microinjected neurons was not
caused by partial inhibition of the PI-3-kinase-signaling pathway
with LY294002, because 50 M LY294002 was effective in com-
pletely inhibiting the phosphorylation of Akt, one of the down-
stream targets of the PI-3-kinase-signaling pathway, in these cells
(Fig. 3B) (Tsui-Pierchala et al., 2000). The observation that in-
hibiting PI-3-kinase signaling with LY294002 induced only partial
development of competence indicates that NGF signals to inhibit
the development-of-competence pathway by using both PI-3-
kinase-dependent and PI-3-kinase-independent mechanisms.
Cytochrome c-induced death in competent
sympathetic neurons uses the caspase-9-dependent
apoptotic pathway
Cell death induced by microinjection of cytochrome c in compe-
tent sympathetic neurons is caspase dependent, because the pan-
caspase inhibitor BAF blocks this death (Deshmukh and John-
son, 1998). Although several in vitro studies indicate that
cytochrome c induces caspase activation via the Apaf-1 and
caspase-9-mediated pathway (Budihardjo et al., 1999), whether
microinjected cytochrome c activates this pathway in sympathetic
neurons is unclear. Sympathetic neuronal apoptosis after NGF
deprivation requires caspase-9 (Deshmukh et al., 2000). There-
fore, we examined whether sympathetic neuronal death induced
by microinjection of cytochrome c was also caspase-9 dependent.
Sympathetic neurons from caspase-9-deficient mice (/) or the
wild-type littermates (/) were either maintained in NGF or
deprived of NGF in the presence of cycloheximide for 48 hr and
then microinjected with cytochrome c. Microinjection of cyto-
chrome c induced rapid cell death in the NGF-deprived,
cycloheximide-treated neurons obtained from wild-type mice
(Fig. 4). However, microinjection of cytochrome c was incapable
of inducing cell death in NGF-deprived, cycloheximide-treated
neurons that were deficient in caspase-9 (Fig. 4). As expected,
microinjection of cytochrome c did not induce cell death in
NGF-maintained neurons from either wild-type or caspase-9-
deficient mice.
We also examined whether microinjected cytochrome c in-
Figure 3. Inhibition of the PI-3-kinase signaling pathway induces partial
development of competence in NGF-maintained sympathetic neurons. A,
Bax-deficient sympathetic neurons were maintained in NGF (NGF ),
deprived of NGF (NGF ), or maintained in NGF in the presence of a 50
M concentration of the PI-3-kinase inhibitor LY294002 (NGFLY )
for 36 hr. Bax deficiency permits these neurons to be deprived of NGF or
to be treated with LY294002 yet remain alive to allow for the microin-
jection experiments. Neurons were then microinjected with cytochrome c
(10 mg/ml) and rhodamine dextran (C) or rhodamine dextran alone (R),
and the number of cells injected was determined as described in the
legend to Figure 1. Results are the means  SEM for three experiments
with 100 cells counted for each time point per experiment. B, A 50 M
concentration of LY294002 inhibits the PI-3-kinase signaling-mediated
phosphorylation of its substrate Akt in NGF-maintained sympathetic
neurons. Western immunoblots show lysates of NGF-maintained sympa-
thetic neurons either alone or in the presence of 50 M LY294002 for 36
hr that were probed with an anti-phospho-specific Akt ( p-Akt) antibody
to assess the inhibition of the PI-3-kinase signaling in neurons. Lysates
were also probed with an anti-tubulin ( Tubulin) antibody as a loading
control.
Figure 4. Caspase-9 is required for cytochrome c-induced cell death in
sympathetic neurons. Sympathetic neurons from caspase-9-deficient mice
(/) or their wild-type littermates (/) were either maintained in
NGF (NGF ) or deprived of NGF in the presence of 1 g/ml cyclohex-
imide (NGFCHX ) for 36 hr. Cells were then microinjected with
cytochrome c (10 mg/ml), and the number of cells remaining viable 3, 6,
and 10 hr after the injections was determined as described in the legend
to Figure 1. Microinjection of cytochrome c induces rapid cell death in
competent, wild-type (/) but not caspase-9-deficient (/) neurons.
Data shown are means  range of two experiments with 100 cells
counted for each time point per experiment.
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duced cell death in competent sympathetic neurons by activating
caspase-3. Activation of caspase-3 was determined by immuno-
staining with the CM1 antibody that recognizes the activated but
not the zymogen form of caspase-3 (Srinivasan et al., 1998).
Microinjection of cytochrome c produced CM1 staining in com-
petent, NGF-deprived, cycloheximide-treated neurons but not in
NGF-maintained sympathetic neurons (Fig. 5). Together, these
experiments indicate that cytosolic cytochrome c induced cell
death in competent sympathetic neurons by activating a caspase-
9-dependent, caspase-3-mediated apoptotic pathway.
Readdition of NGF to competent sympathetic neurons
restores resistance to cytosolic cytochrome c:
reversal of competence is slow and requires new
protein synthesis
NGF-maintained sympathetic neurons develop competence only
after 24–36 hr of NGF deprivation and by a mechanism that does
not require protein synthesis (Deshmukh and Johnson, 1998). To
determine whether this process is reversible, we examined
whether readdition of NGF to competent neurons results in the
loss of competence and promotes resistance to cytosolic cyto-
chrome c. NGF-deprived, cycloheximide-saved sympathetic neu-
rons that had developed competence were washed and re-exposed
to NGF-containing medium. At various times after NGF readdi-
tion, neurons were microinjected with cytochrome c to determine
whether these neurons had developed resistance to cytosolic
cytochrome c. Readdition of NGF to competent neurons resulted
in complete loss of competence (Fig. 6). However, the reversal of
competence was slow, and neurons regained complete resistance
to cytosolic cytochrome c only after 12–24 hr of NGF readdition
(Fig. 6). We also examined whether competence could be re-
versed with the addition of KCl or CPTcAMP. Like NGF read-
dition, exposure to 35 mM KCl or 400 M CPTcAMP also
induced the reversal of competence and promoted the resistance
to cytosolic cytochrome c by a similar time course (Fig. 6).
To determine whether the reversal of competence required
new protein synthesis, we examined whether macromolecular
synthesis inhibitors prevented the ability of NGF to reverse com-
petence. NGF was readded to NGF-deprived, competent neurons
alone or in the presence of RNA or protein synthesis inhibitor,
actinomycin D, or cycloheximide, respectively. Competent sym-
pathetic neurons that were treated with NGF readdition alone
reversed competence and became resistant to cytosolic cyto-
chrome c by 12 hr after NGF readdition (Figs. 6, 7A). However,
RNA or protein synthesis inhibitor blocked the ability of NGF to
reverse competence. Neurons that were treated with NGF read-
dition in the presence of either actinomycin D or cycloheximide
remained sensitive to cytosolic cytochrome c and died rapidly
after microinjection of cytochrome c even after 12 hr of NGF
readdition (Fig. 7A). Actinomycin D or cycloheximide also pre-
vented the ability of KCl and CPTcAMP to reverse competence.
Competent neurons that were treated with KCl or CPTcAMP
for 12 hr in the presence of actinomycin D or cycloheximide
remained sensitive to cytochrome c and died rapidly with cyto-
solic microinjection of cytochrome c (Fig. 7B,C).
Thus, the competence state of sympathetic neurons was revers-
ible. However, although the development of competence was not
protein synthesis dependent, the reversal of competence surpris-
ingly required new protein synthesis. These results are consistent
with the model in which the synthesis of a protein that inhibits
cytochrome c-mediated caspase activation (either directly or in-
directly) is needed for the reversal of competence. Consequently,
the development of competence may involve the inactivation or
degradation of such a caspase inhibitory protein.
Figure 5. Caspase-3 is activated in the NGF-deprived, cycloheximide-
treated, competent neurons but not in the NGF-maintained neurons after
microinjection with cytochrome c. Mouse sympathetic neurons were ei-
ther maintained in NGF (NGF ) or deprived of NGF in the presence of
1 g/ml cycloheximide (NGFCHX ). Cells were microinjected with
cytochrome c (10 mg/ml) along with a nonspecific (IgG) mouse mono-
clonal antibody to mark the injected cells. Four hours later, the injected
cells were fixed and incubated with anti-activated-caspase-3 (CM1) anti-
bodies (rabbit). Anti-mouse (for IgG) and anti-rabbit (for CM1) second-
ary antibodies were then used to immunostain the cells. Photomicro-
graphs of representative cells (arrows mark the injected cells) show
caspase-3 activation in competent (NGFCHX ) but not in NGF-
maintained (NGF ) neurons after microinjection of cytochrome c. Scale
bar, 20 m.
Figure 6. Time course of loss of competence with readdition of NGF,
KCl, or cAMP. Mouse sympathetic neurons that had developed compe-
tence (NGF deprived and cycloheximide treated for 36 hr) were treated
with the addition of NGF (NGF ), 400 M CPTcAMP (cAMP), or 35
mM KCl (KCl ). At the times indicated after the addition of these agents,
cells were microinjected with cytochrome c (10 mg/ml) to examine the
competence state of these cells. Competence was assessed by examining
survival 6 hr after microinjection of cytochrome c as described in the
legend to Figure 1. Note that at time 0 (fully competent cells), only 10%
of the injected cells survive injection of cytochrome c. However, 12 hr
after the addition of NGF (or KCl or CPTcAMP), 80% of the cells
have lost competence and survive microinjection of cytochrome c. Data
shown are means  range of two experiments with 100 cells counted for
each time point per experiment.
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Cytosolic microinjection of Smac induces competence
and permits cytochrome c-mediated cell death in
NGF-maintained sympathetic neurons
We considered the possibility that the caspase-inhibitory protein
regulating competence in sympathetic neurons might belong to
the inhibitor of apoptosis (IAP) family of proteins. IAP proteins
such as X-linked IAP (XIAP), inhibitor of apoptosis-1 (cIAP-1),
and cIAP-2 bind to caspases and are potent inhibitors of their
activation in vitro (Deveraux and Reed, 1999). Overexpression of
these proteins prevents apoptosis in many cells, including chicken
sympathetic neurons (Wiese et al., 1999) and cerebellar granule
neurons (Simons et al., 1999). Thus, the inability of cytosolic
cytochrome c to induce cell death in NGF-maintained sympa-
thetic neurons could be attributable to caspase inhibition by the
IAP family of proteins.
To examine this, we used the recently identified Smac protein
that can bind to and inhibit IAP function (Du et al., 2000;
Verhagen et al., 2000). We asked whether cytosolic microinjec-
tion of mature Smac would permit cytochrome c to induce cell
death in NGF-maintained sympathetic neurons. Because mature
Smac can bind to and inhibit several IAPs in vitro, microinjection
of Smac in the cytosol allowed us potentially to inhibit multiple
IAPs in these neurons, thereby overcoming any complexity
caused by functional redundancy of IAPs in these cells. Cytosolic
microinjection of mature Smac alone was insufficient to induce
cell death in NGF-maintained sympathetic neurons (Fig. 8A). As
expected, cytosolic microinjection of cytochrome c alone also did
not induce cell death in NGF-maintained sympathetic neurons.
However, coinjection of cytochrome c and Smac remarkably
induced a rapid, caspase-dependent death in these NGF-
maintained neurons (Fig. 8A). Thus, exogenous cytosolic mature
Smac was sufficient to induce competence rapidly and permit
cytochrome c-mediated cell death in NGF-maintained sympa-
thetic neurons. Cytosolic microinjection of Smac and cytochrome
c also induced rapid cell death in KCl- or CPTcAMP-maintained
neurons (data not shown). The ability of Smac to convert rapidly
NGF-maintained neurons from being resistant to being sensitive
to cytosolic cytochrome c indicates that exogenous cytosolic ma-
ture Smac induced events in these neurons that were functionally
indistinguishable from those induced by the development-of-
competence pathway after 24–36 hr of NGF deprivation.
To determine whether the N-terminal IAP-inhibiting domain
of mature Smac was important for its ability to permit cytochrome
c to activate caspases in sympathetic neurons, we examined
whether microinjection of Smac , an alternatively spliced form of
Smac that lacks this N-terminal IAP-binding domain, could also
promote cytochrome c-mediated caspase activation in these neu-
rons. Smac  is identical to mature Smac except in the first seven
amino acids; this sequence corresponds to MKSDFYF in Smac 
and AVPIA in mature Smac (Srinivasula et al., 2000; Roberts et
al., 2001). Because the N-terminal AVPI motif in mature Smac is
critical for interacting with the baculovirus IAP repeat-3 (BIR-3)
domain of IAPs and for relieving the XIAP–caspase-9 inhibition
(Liu et al., 2000; Wu et al., 2000), Smac  is unable to interact
with the BIR-3 domain of IAPs and, as a consequence, is inef-
fective in blocking the XIAP inhibition of caspase-9 (Srinivasula
et al., 2000). Unlike mature Smac, microinjection of Smac  and
cytochrome c was unable to promote any significant cell death in
NGF-maintained sympathetic neurons even 24 hr after the injec-
tions (Fig. 8B). As expected, microinjection of Smac, Smac , or
cytochrome c alone also did not promote any cell death in these
neurons (Fig. 8B). Thus, the N-terminal IAP (BIR-3)-interacting
Figure 7. Reversal of competence requires macromolecular synthesis. A,
Mouse sympathetic neurons that had developed competence (NGF deprived
and cycloheximide treated for 36 hr) were treated for 12 hr with NGF alone
(NGF), NGF with 0.1 g/ml actinomycin-D (NGFactD), or NGF with
1 g/ml cycloheximide (NGFCHX). Cells were then microinjected with
cytochrome c, and the competence state was determined by assessing the
survival as described in the legend to Figure 1. B, Mouse sympathetic neu-
rons that had developed competence (NGF deprived and cycloheximide
treated for 36 hr) were treated for 12 hr with 35 mM KCl alone (KCl), KCl
in the presence of 0.1 g/ml actinomycin D (KClactD), or 1 g/ml
cycloheximide (KClCHX), and the competence status of these cells was
assessed exactly as described in A. C, Mouse sympathetic neurons that had
developed competence (NGF deprived and cycloheximide treated for 36 hr)
were treated for 12 hr with 400 M CPTcAMP alone (cAMP), CPTcAMP
in the presence of 0.1 g/ml actinomycin D (cAMPactD), or 1 g/ml
cycloheximide (cAMPCHX), and the competence status of these cells
was assessed exactly as described in A and Figure 1. As seen in Figure 6, the
addition of NGF, KCl, or CPTcAMP reversed competence by 12 hr after
factor addition. However, RNA and protein synthesis inhibitors (actino-
mycin-D and cycloheximide, respectively) blocked the ability of NGF, KCl,
or CPTcAMP to reverse competence, because these cells remained suscep-
tible to microinjection of cytochrome c. Data shown are means  range of
two to three experiments with 100 cells counted for each time point per
experiment.
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domain of mature Smac was essential for promoting cytochrome
c-mediated caspase activation in NGF-maintained sympathetic
neurons. These results indicate that the inability of cytochrome c
alone to activate caspases in these neurons was attributable to the
presence of an IAP family protein(s) that could be overcome with
exogenous cytosolic microinjection of mature Smac.
DISCUSSION
Signaling mechanism of the
development-of-competence pathway
NGF deprivation activates the cytochrome c release and
development-of-competence pathways in sympathetic neurons,
both of which are required for apoptosis in these cells. These two
pathways must diverge at some point after NGF deprivation,
because whereas the cytochrome c release pathway is dependent
on macromolecular synthesis and Bax function, the development-
of-competence pathway requires neither macromolecular synthe-
sis nor Bax function (Deshmukh and Johnson, 1998). We have
determined that the neuroprotective agents KCl and CPTcAMP
block the development of the competence pathway in NGF-
deprived neurons (Fig. 2). Because KCl and CPTcAMP also
inhibit the cytochrome c-release pathway after NGF deprivation
(Putcha et al., 1999), both KCl and CPTcAMP most likely act at
a point before the divergence of these two pathways to prevent
sympathetic neuronal apoptosis.
We also examined the specific importance of the PI-3-kinase/
Akt-signaling pathway in regulating competence in sympathetic
neurons because of the reported survival-promoting importance
of this pathway in neurons (Datta et al., 1999). Our results show
that inhibition of the endogenous PI-3-kinase-signaling pathway
with LY294002 induced partial activation of the development-of-
competence pathway in NGF-maintained sympathetic neurons
(Fig. 3). Thus, the PI-3-kinase-signaling pathway appeared criti-
cal, but only in part, for keeping the development-of-competence
pathway inhibited in NGF-maintained sympathetic neurons.
Overexpression of activated Akt (one of the downstream targets
of the PI-3-kinase-signaling pathway) prevents apoptosis after
cytochrome c release in hybrid motor neuron 1 cells (Zhou et al.,
2000). Thus, signaling through the PI-3-kinase/Akt-pathway may
post-translationally modify components of the apoptosome com-
plex and prevent caspase activation. Alternatively, because the
PI-3-kinase-signaling pathway is important for maintaining the
trophic and metabolic status of NGF-maintained sympathetic
neurons (Tsui-Pierchala et al., 2000), PI-3-kinase signaling may
prevent caspase activation indirectly by sustaining the macromo-
lecular synthesis of proteins such as the IAPs (see below). Con-
sistent with this hypothesis, PI-3-kinase-signaling pathway was
shown to be important for the continued expression of ITA, an
IAP family protein, in NGF-maintained chicken sensory and
sympathetic neurons (Wiese et al., 1999). In the absence of NGF
or if the PI-3-kinase pathway is inhibited, the expression of such
proteins may decrease, thereby permitting cytochrome
c-mediated caspase activation in these neurons.
Importance of the caspase-9-dependent pathway in
sympathetic neuronal apoptosis
Our results show that in the absence of caspase-9, microinjected
cytochrome c was unable to induce any cell death in competent
sympathetic neurons (Fig. 4). These results indicate that
caspase-9 was the only caspase capable of being activated by
cytosolic cytochrome c to induce cell death in sympathetic neu-
rons. These data are consistent with our previous observation that
caspase-9-deficient sympathetic neurons are unable to undergo
apoptosis after NGF deprivation (Deshmukh et al., 2000).
Our results also show that cytosolic cytochrome c induced
caspase-3 activation in competent sympathetic neurons (Fig. 5).
Figure 8. Cytosolic microinjection of Smac induces competence in NGF-
maintained sympathetic neurons. A, NGF-maintained mouse sympathetic
neurons were microinjected with cytochrome c (15 mg/ml) alone (Cytc),
Smac (0.6 mg/ml) alone (Smac), or cytochrome c and Smac (CytcSmac).
Parallel cultures of sympathetic neurons that were deprived of NGF in the
presence of cycloheximide for 36 hr were injected with cytochrome c
[NGFCHX(Cytc)] as a positive control for competence. Viability of
microinjected cells 3, 6, and 12 hr after these injections was determined as
described in the legend to Figure 1. Some NGF-maintained cultures that
were injected with cytochrome c and Smac together were also treated with
the pan-caspase inhibitor BAF (50 M) to examine whether the cell death
induced by cytochrome c and Smac was caspase dependent. Microinjec-
tion of Smac and cytochrome c, but neither alone, induced rapid cell
death in NGF-maintained sympathetic neurons. B, Microinjection of
Smac  does not induce competence in sympathetic neurons. NGF-
maintained mouse sympathetic neurons were microinjected with cyto-
chrome c (15 mg/ml) and either Smac (0.6 mg/ml) or Smac  (0.6 mg/ml).
Control cells were also microinjected with cytochrome c, Smac, or Smac
 alone. Viability of microinjected cells 24 hr after the injections is shown.
Unlike Smac, Smac  is not able to promote caspase activation with
cytochrome c in these neurons. Data shown are means  range of two
experiments with 100 cells counted for each time point per experiment.
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Activation of caspase-3 presumably occurred from a direct acti-
vation by caspase-9 in these neurons. Importantly, we did not
detect any activated caspase-3 in NGF-maintained neurons mi-
croinjected with cytosolic cytochrome c (Fig. 5). These results
indicate that the inability of cytosolic cytochrome c to induce cell
death in NGF-maintained sympathetic neurons was because of a
specific block either at, or upstream of, caspase-3 activation in
these neurons.
Reversal of competence requires new
protein synthesis
NGF deprivation induces the development of competence by a
process that takes 24 hr and does not require protein synthesis
(Deshmukh and Johnson, 1998). We report that this state of
competence was reversible if NGF (or KCl or CPTcAMP) was
added to the NGF-deprived, competent neurons (Fig. 6). Nota-
bly, although the development of competence does not require
protein synthesis, the reversal of competence was completely
dependent on new protein synthesis (Fig. 7). Addition of cyclo-
heximide or actinomycin D completely prevented the ability of
NGF, KCl, or CPTcAMP to reverse competence, and neurons
remained sensitive to cytosolic microinjection of cytochrome c.
Inhibiting protein synthesis with cycloheximide was consistently
more effective in preventing the reversal of competence than
inhibiting RNA synthesis with actinomycin D (Fig. 7). This is not
surprising, because cycloheximide would inhibit all de novo pro-
tein synthesis, whereas actinomycin D would not be able to inhibit
the synthesis of proteins that use mRNAs already present in cells.
The requirement of macromolecular synthesis for reversal of
competence indicates that competent sympathetic neurons need
to synthesize some protein to regain resistance to cytosolic cyto-
chrome c. Such a protein must prevent cytochrome c-mediated
caspase activation either directly or indirectly in these NGF-
treated neurons.
Cytosolic Smac is sufficient to induce competence in
sympathetic neurons
The remarkable ability of microinjected, cytosolic mature Smac
to induce competence and permit cytochrome c to induce cell
death in NGF-maintained neurons (Fig. 8) has two important
implications. First, these results indicate that the absolute resis-
tance of NGF-maintained sympathetic neurons to cytosolic cyto-
chrome c is caused by a block in caspase activation by a Smac-
inhibitable, IAP family protein(s). Second, that Smac and
cytochrome c induced caspase-dependent cell death in NGF-
maintained neurons only when microinjected together, but nei-
ther alone, indicates that simply overcoming the IAP inhibition
with exogenous Smac is not sufficient to activate caspases in these
neurons. Our results also show that unlike mature Smac, Smac 
was ineffective in inducing competence (Fig. 8B). Because Smac
 specifically lacks the IAP BIR-3-interacting domain, and be-
cause the BIR-3 domain has been implicated in inhibiting
caspase-9 (Shi, 2002), these results point to IAP inhibition of
caspase-9 as an important point of regulation of caspase activa-
tion in sympathetic neurons. We note that the ability of endoge-
nous IAPs to inhibit caspase-9 activation in sympathetic neurons
has also been implicated in another recent report (Troy et al.,
2001). Together, these results indicate that caspase activation in
sympathetic neurons requires both the accumulation of cyto-
chrome c in the cytosol and the elimination of some IAP-like
protein that otherwise keeps caspases inhibited in these neurons.
How might NGF deprivation induce competence and permit
caspase activation in sympathetic neurons? One consequence of
NGF deprivation is a dramatic reduction in the global rate of
protein synthesis in these neurons (Deckwerth and Johnson,
1993). Therefore, NGF deprivation may induce competence by
reducing the levels of IAPs simply as a result of a fall in global
protein synthesis rates. This seems unlikely to be the major
mechanism, because inhibiting protein synthesis alone for 24 hr is
not sufficient to induce competence in NGF-maintained sympa-
thetic neurons (Deshmukh and Johnson, 1998). More likely, the
degradation or inhibition of IAPs in competent neurons is an
active process that is triggered with NGF deprivation. For exam-
ple, the NGF deprivation-induced development-of-competence
pathway may activate post-translational mechanisms that target
the IAPs for degradation or somehow prevent the interactions of
IAPs with caspases. The proteasome-mediated degradation of
IAPs has been observed in thymocytes undergoing apoptosis
(Yang et al., 2000).
The development-of-competence pathway may also achieve
inhibition of IAPs by promoting the cytosolic translocation of
endogenous Smac or other proteins such as HtrA2 that inhibit
IAPs (Suzuki et al., 2001; Hegde et al., 2002; Martins et al., 2002;
Verhagen et al., 2002). If this were so, such proteins must trans-
locate to the cytosol under conditions in which neurons develop
competence and cytochrome c remains sequestered in the mito-
chondria (i.e., in the NGF-deprived, cycloheximide-treated or the
NGF-deprived, Bax-deficient neurons). However, this seems un-
likely, because Smac (or HtrA2) appears to be released only with
or after cytochrome c in the experimental models in which this
has been examined (Du et al., 2000; Verhagen et al., 2000; Adrain
et al., 2001; Suzuki et al., 2001).
The observation that microinjection of cytosolic Smac was
sufficient to permit cytochrome c to activate caspases raises an
important question of whether the competence pathway and the
release of Smac (or HtrA2) from the mitochondria are redundant
mechanisms for inhibiting the IAPs in these neurons. We specu-
late that the critical function of IAPs in regulating caspase
activation in sympathetic neurons is a failsafe mechanism that
would prevent unwanted caspase activation if any accidentally
damaged mitochondria (or during normal mitochondrial turn-
over) release cytochrome c in neurons. For such a mechanism to
be effective, the IAPs must also withstand any inhibition with
Smac that may be released along with cytochrome c in such
accidental situations. In contrast, situations such as NGF with-
drawal that activate the physiological programmed cell death
pathway must completely eliminate the IAP block and permit
cytochrome c to activate caspases and induce apoptosis. There-
fore, we propose that the competence pathway that is activated
after NGF deprivation must be the predominant mechanism that
removes the IAPs (probably by promoting its degradation), and
that Smac, if released along with cytochrome c, would be a
secondary mechanism that would ensure the complete and rapid
elimination of IAPs so as to allow cytochrome c to activate
caspases and induce apoptosis. The recent report describing the
lack of any significant defect in the Smac knock-out mice is
consistent with our hypothesis and argues against the critical
importance of Smac per se in promoting caspase activation
(Okada et al., 2002). In our microinjection studies, however, Smac
may have been sufficient to permit caspase activation, most likely
because the concentration of Smac used in these experiments was
significantly greater than the intracellular concentration of Smac
in these neurons.
This stringent regulation of caspase activation beyond cyto-
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chrome c release in sympathetic neurons provides a strong ratio-
nale for the functional existence of IAPs and their inhibitors in
these neurons. The sufficiency of microinjected cytochrome c
alone to induce cell death in most other cells in which this has
been examined argues against this being a generalized mecha-
nism by which caspase activation is regulated in most cells (Li et
al., 1997; Brustugun et al., 1998; Juin et al., 1999; Chang et al.,
2000). As discussed above, in NGF-maintained sympathetic neu-
rons, such a regulation provides a failsafe mechanism that pre-
vents any accidental activation of caspases and thereby ensures
the long-term survival of these neurons. Other postmitotic cells
that also need to last for the lifetime of the organism may also
regulate caspase activation beyond cytochrome c release by a
similar mechanism.
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